Approximately 90% of men who undergo prostate cancer treatment and nearly 50% of men treated for other cancers experience some degree of sexual dysfunction or erectile challenges, according to recent data. Yet, most patients rarely discuss these issues, suffering in silence when help is available.
This gap in care highlights a critical need for integrating sexual health support into cancer treatment plans. Medical experts emphasize that addressing sexual dysfunction can significantly improve quality of life for cancer survivors. Treatments range from medications and devices to counseling and lifestyle changes.
As companies like Calidi Biotherapeutics Inc. (NYSE American: CLDI) advance research into cancer therapies with fewer side effects, the hope is that future treatments will minimize sexual health impacts. However, for current patients, proactive communication with healthcare providers is essential.
Urologists and oncologists recommend that men discuss sexual health concerns early, as many issues are treatable. Penile rehabilitation programs, oral medications, vacuum devices, and injections are among the options. Additionally, psychological support can help address anxiety and relationship challenges.
Despite the prevalence of sexual dysfunction, stigma and embarrassment often prevent men from seeking help. Awareness campaigns and patient education are vital to change this dynamic. Healthcare systems are encouraged to routinely screen for sexual health issues during cancer follow-ups.
The importance of this issue is underscored by the growing number of cancer survivors. With advances in treatment, more men are living longer after cancer, making post-treatment quality of life a priority. Sexual health is a key component of overall well-being.
Organizations like the American Cancer Society and the Prostate Cancer Foundation provide resources to help patients and partners navigate these challenges. Support groups and online forums also offer a platform for sharing experiences and advice.
For more information on available treatments and support, visit BioMedWire for ongoing coverage of biomedical innovations and patient care strategies.
